BIOMAT Database Logo BIOMAT Database Logo

Formation of toxic metabolites from drugs and other xenobiotics by glutathione conjugation. 1988

P J van Bladeren

UI MeSH Term Description Entries
D004364 Pharmaceutical Preparations Drugs intended for human or veterinary use, presented in their finished dosage form. Included here are materials used in the preparation and/or formulation of the finished dosage form. Drug,Drugs,Pharmaceutical,Pharmaceutical Preparation,Pharmaceutical Product,Pharmaceutic Preparations,Pharmaceutical Products,Pharmaceuticals,Preparations, Pharmaceutical,Preparation, Pharmaceutical,Preparations, Pharmaceutic,Product, Pharmaceutical,Products, Pharmaceutical
D005978 Glutathione A tripeptide with many roles in cells. It conjugates to drugs to make them more soluble for excretion, is a cofactor for some enzymes, is involved in protein disulfide bond rearrangement and reduces peroxides. Reduced Glutathione,gamma-L-Glu-L-Cys-Gly,gamma-L-Glutamyl-L-Cysteinylglycine,Glutathione, Reduced,gamma L Glu L Cys Gly,gamma L Glutamyl L Cysteinylglycine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014116 Toxicology The science concerned with the detection, chemical composition, and biological action of toxic substances or poisons and the treatment and prevention of toxic manifestations. Toxinology,Evidence Based Toxicology,Evidence-Based Toxicology,Based Toxicologies, Evidence,Based Toxicology, Evidence,Evidence Based Toxicologies,Evidence-Based Toxicologies,Toxicologies, Evidence Based,Toxicologies, Evidence-Based,Toxicology, Evidence Based,Toxicology, Evidence-Based

Related Publications

P J van Bladeren
Bioactivation of xenobiotics by formation of toxic glutathione conjugates.
January 1991, Chemico-biological interactions,
P J van Bladeren
Glutathione conjugation of some xenobiotics by Ascaris suum and Moniezia expansa.
March 1978, Xenobiotica; the fate of foreign compounds in biological systems,
P J van Bladeren
[The biochemical basis of toxic actions of drugs and other xenobiotics].
July 1993, Pharmazie in unserer Zeit,
P J van Bladeren
Therapeutic and toxic blood concentrations of nearly 1,000 drugs and other xenobiotics.
July 2012, Critical care (London, England),
P J van Bladeren
Therapeutic and toxic blood concentrations of more than 800 drugs and other xenobiotics.
July 2003, Die Pharmazie,
P J van Bladeren
Revisited: Therapeutic and toxic blood concentrations of more than 1100 drugs and other xenobiotics.
May 2020, Critical care (London, England),
P J van Bladeren
Bioactivation of nephrotoxic haloalkenes by glutathione conjugation: formation of toxic and mutagenic intermediates by cysteine conjugate beta-lyase.
January 1989, Drug metabolism reviews,
P J van Bladeren
Drugs and other xenobiotics as teratogens.
January 1984, Pharmacology & therapeutics,
P J van Bladeren
Designing safer (soft) drugs by avoiding the formation of toxic and oxidative metabolites.
February 2004, Molecular biotechnology,
P J van Bladeren
Designing safer (soft) drugs by avoiding the formation of toxic and oxidative metabolites.
January 2002, Methods in molecular biology (Clifton, N.J.),
Copied contents to your clipboard!